Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response.

Li, Zhanzhan; Li, Yanyan; Tian, Yifu; Li, Na; Shen, Liangfang; Zhao, Yajie

Li, Zhanzhan; Li, Yanyan; Tian, Yifu; Li, Na; Shen, Liangfang; Zhao, Yajie.

Afiliação

Li Z; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Li Y; Department of Nursing, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Tian Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Li N; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhao Y; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Front Immunol ; 14: 1170539, 2023.

Article em En | MEDLINE | ID: mdl-37275863

Assuntos

Glioma; Timosina; Humanos; Prognóstico; Imunoterapia; Timosina/genética; Inibidores de Checkpoint Imunológico; Microambiente Tumoral/genética

Palavras-chave

TMSB10; immune infiltration; immunotherapy; pan-cancer; prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timosina / Glioma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google